Our results confirmed the published data that miR-128 inhibits glioma proliferation and self-renewal via targeting Bmi-1 [8] and revealed a new mechanism by which miR128-1 is deregulated in glioma. This evidence concerns the gene BMI1 and central nervous system cancer.